Biomedical Engineering Reference
In-Depth Information
337. Crouzier, D.; Follot, S.; Gentilhomme, E.; Flahaut, E.; Arnaud, R.; Dabouis, V., et al. Carbon
Nanotubes Induce Inflammation but Decrease the Production of Reactive Oxygen Species in
Lung.
Toxicology
2010,
272,
39-45.
338. Ehrenberg, M.; Friedman, A.; Finkelstein, J.; Oberdorster, G.; McGrath, J. The Influence of
Protein Adsorption on Nanoparticle Association with Cultured Endothelial Cells.
Biomateri-
als
2009,
30,
603-610.
339. Elgrabli, D.; Abella-Gallart, S.; Robidel, F.; Rogerieux, F.; Boczkowski, J.; Lacroix, G. Induc-
tion of Apoptosis and Absence of Inflammation in Rat Lung after Intratracheal Instillation of
Multiwalled Carbon Nanotubes.
Toxicology
2008,
253,
131-136.
340. Jia, G.; Wang, H.; Yan, L.; Wang, X.; Pei, R.; Yan, T.; Zhoa, Y.; Guo, X. Cytotoxicity of Car-
bon Nanomaterials: Single-wall Nanotube, Multi-wall Nanotube, and Fullerene.
Environ. Sci.
Technol.
2005,
39,
1378-1383.
341. Kreyling, W. G.; Möller, W.; Semmler-Behnke, M.; Oberdörster, G. In
Particle Toxicology
;
Born, D. K., Ed.; CRC Press: Boca Raton, 2007.
342. Lam, C. W.; James, J. T.; McCluskey, R.; Arepalli, S.; Hunter, R. L. A Review of Carbon
Nanotube Toxicity and Assessment of Potential Occupational and Environmental Health
Risks.
Crit. Rev. Toxicol.
2006,
36,
189-217.
343. Lubbe, A. S.; Begemann, C.; Brock, J.; McClure, D. G. Physiological Aspects in Magnetic
Drug-Targeting.
J. Magn. Magn. Mater.
1999,
194,
7.
344. Muller, R. H.; Maassen, S.; Weyhers, H.; Mehnert, W. Phagocytic Uptake and Cytotoxicity of
Solid Lipid Nanoparticles (SLN) Sterically Stabilized with Poloxamine 908 and Poloxamer
407.
J. Drug Target.
1996,
4,
161-170.
345. Zhang, Y.; Kohler, M.; Zhang, M. Surface Modification of Superparamagnetic Magnetite
Nanoparticles and their Interacellular Uptake.
Biomaterials
2002,
23,
9.
346. Alexiou, C.; Arnold, W.; Klein, R. J., et al. Locoregional Cancer Treatment with Magnetic
Drug Targeting.
Cancer Res.
2006,
60,
6641-6648.
347. Allen, T. M.; Mumbengegwi, D. R.; Charrois, G. J. Anti-CD19-targeted Liposomal Doxorubi-
cin Improves the Therapeutic Efficacy in Murine B-cell Lymphoma and Ameliorates the Tox-
icity of Liposomes with Varying Drug Release Rates.
Clin. Cancer Res.
2005,
11,
3567-3573.
348. Bertholon, I.; Ponchel, G.; Labarre, D.; Couvreur, P.; Vauthier, C. Bioadhesive Properties of
Poly(alkylcyanoacrylate) Nanoparticles Coated with Polysaccharide.
J. Nanosci. Nanotech-
nol.
2006,
6,
3102-3109.
349. Beyerle, A.; Merkel, O.; Stoeger, T.; Kissel, T. PEGylation Affects Cytotoxicity and Cell-
compatibility of Poly(ethylene imine) for Lung Application: Structure Function Relation-
ships.
Toxicol. Appl. Pharmacol.
2010,
242,
146-154.
350. Lübbe, A. S.; Alexiou, C.; Bergemann, C. Clinical Applications of Magnetic Drug Targeting.
J. Surg. Res.
2001,
95,
200-206.
351. Mykhaylyk, O. M.; Dudchenko, N. O.; Dudchenko, A. K. Pharmacokinetics of the Doxorubi-
cin Magnetic Nanoconjugate in Mice Effects of the Nonuniform Stationary Magnetic Field.
Ukr Biokhim Zh
2005,
77,
80-92.
352. Nguyen, S.; Hiorth, M.; Rykke, M.; Smistad, G. The Potential of Liposomes as Dental Drug
Delivery Systems.
Eur. J. Pharm. Biopharm.
2011,
77,
75-83.
353. Mingo, G.; Scholzen, A.; Tang, C. K.; Hanley, J. C.; Kalkainidis, M.; Pietersz, G. A.; Aposto-
lopoulos, V.; Plebanski, M. Poly-L-Lysine-Coated Nanoparticles: A Potent Delivery System to
Enhance DNA Vaccine Efficacy.
Vaccine
2007,
25,
1316-1327.
354. Ferber, D. Microbes made to order.
Science
2004,
303,
158-161.
355. Topoglidis, E. A.; Cass, E., et al. Protein Adsorption on Nanocrystalline TiO
2
Films: An
Immobilization Strategy for Bioanalytical Devices.
Anal. Chem.
1998,
70,
5111-5113.
